Advertisement
Canada markets open in 1 hour 25 minutes
  • S&P/TSX

    21,788.48
    -60.11 (-0.28%)
     
  • S&P 500

    5,469.30
    +21.43 (+0.39%)
     
  • DOW

    39,112.16
    -299.05 (-0.76%)
     
  • CAD/USD

    0.7308
    -0.0015 (-0.20%)
     
  • CRUDE OIL

    81.28
    +0.45 (+0.56%)
     
  • Bitcoin CAD

    84,161.86
    +526.87 (+0.63%)
     
  • CMC Crypto 200

    1,273.57
    -10.21 (-0.80%)
     
  • GOLD FUTURES

    2,324.90
    -5.90 (-0.25%)
     
  • RUSSELL 2000

    2,022.35
    -8.47 (-0.42%)
     
  • 10-Yr Bond

    4.2380
    -0.0100 (-0.24%)
     
  • NASDAQ futures

    19,991.75
    +19.50 (+0.10%)
     
  • VOLATILITY

    13.02
    +0.18 (+1.40%)
     
  • FTSE

    8,232.69
    -15.10 (-0.18%)
     
  • NIKKEI 225

    39,667.07
    +493.92 (+1.26%)
     
  • CAD/EUR

    0.6831
    -0.0001 (-0.01%)
     

Stocks in play: Bee Vectoring Technologies International Inc

Announces it is exploring strategic alternatives, including a potential sale, to enhance the Company’s ability to bring innovative biocontrol technologies to market. This decision is driven by the goal of identifying a more capitalized parent company that can amplify the commercial success of BVT’s groundbreaking solutions. BVT has demonstrated success with its proprietary biological control agent, Clonostachys rosea strain CR-7, in global field trials and is witnessing the early stages of commercialization. Bee Vectoring Technologies International Inc shares C.BEE are trading unchanged at $0.01.

Read: